We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

19 hedge funds and large institutions have $1.47M invested in Bio-Path Holdings Inc in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

12% more funds holding

Funds holding: 1719 (+2)

8% less capital invested

Capital invested by funds: $1.59M → $1.47M (-$128K)

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BPTH Hedge Fund Activity: Q3 2022 in Review

19 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2022, worth a combined $1.47M — down 8% from $1.59M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BPTH positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Mount Yale Investment Advisors, opening a new position worth an estimated $96.3K. The largest seller was Morgan Stanley, cutting an estimated $33.6K.

  • 19 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2022, up from 17 in Q2 2022.
  • Funds reported $1.47M of Bio-Path Holdings Inc stock for Q3 2022, down 8% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q3 2022 and 1 closed out, a net change of +2 holders.
  • The largest Bio-Path Holdings Inc buyer in Q3 2022 was Mount Yale Investment Advisors, an estimated $96.3K added.
  • The largest Bio-Path Holdings Inc seller in Q3 2022 was Morgan Stanley, an estimated $33.6K sold.

Based on aggregated 13F filings for Q3 2022.